Phase 2 study of perioperative lenvatinib (L) with pembrolizumab (P) in patients with locally advanced nonmetastatic clear cell renal cell carcinoma.
Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Mehmet Asim Bilen, Yuan Liu, Amir Davarpanahfakhr, Bassel Nazha, Jacqueline T Brown, Adeboya O. Osunkoya, Sierra Thomson, Wilena Session, Caitlin Hartman, Greta Russler McClintock, Sarah Caulfield, Shreyas Joshi, Vikram M. Narayan, Kenneth Ogan, Omer Kucuk, Bradley Curtis Carthon, Haydn T. Kissick, Viraj A. Master
Institutions: Winship Cancer Institute, Emory University
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4407702388